REQUEST A DEMO
Total
USD $0.00
Search more companies

Nectar Drugs Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Nectar Drugs Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Nectar Drugs Private Limited is an enterprise based in India. Its main office is in Mumbai. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on November 05, 1997. There was a net sales revenue drop of 17.74% reported in Nectar Drugs Private Limited’s latest financial highlights for 2025. Its’ total assets recorded a negative growth of 14.82%. The enterprise’s net profit margin increased by 0.44% in 2025.

Legal Address
B/605/606 Bhaveshwar Arcadelbs Marg Ghatkopar(W)
Mumbai; Maharashtra; Postal Code: 400086

Contact Details: Purchase the Nectar Drugs Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Nectar Drugs Private Limited report to view the information.
Financial Auditors:
Purchase the Nectar Drugs Private Limited report to view the information.
Incorporation Date:
November 05, 1997
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
47%
Purchase this report to view the information.
47%
Company Performance
Financial values in the chart are available after Nectar Drugs Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-17.74%
Total Operating Revenue
-17.38%
Operating Profit
53.84%
EBITDA
51.03%
Net Profit/Loss for the Period
142.48%
Total Assets
-14.82%
Total Equity
2.95%
Operating Profit Margin
0.51%
Net Profit Margin
0.44%
Return on Equity (ROE)
1.64%
Quick Ratio
0.38%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?